ReviewYonsei medical journal2019
Desensitization for Allergic Reactions to Chemotherapy.
Review in Yonsei medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Immune Reactions in Major Types of Oncological Treatment.International journal of molecular sciences · 2023Review
- Canada's First Joint Oncology-Allergy Clinic: Successful Desensitization to Trastuzumab Following Severe Anaphylactic Reaction in Which Epinephrine Was Inappropriately Withheld.Current oncology (Toronto, Ont.) · 2023Article
- Hypersensitivity Reactions to Platinum Agents and Taxanes.Clinical reviews in allergy & immunology · 2022Review
- Desensitization for the prevention of drug hypersensitivity reactions.The Korean journal of internal medicine · 2022Review
- Asfotase Alfa hypersensitivity: an outpatient 8-steps desensitization protocol.Immunologic research · 2021Article
- Implementation of EMR-based standardized antibiotic desensitization protocols and its impact on providers.Allergy and asthma proceedings · 2021Article
- Stevens-Johnson Syndrome Caused by Enzalutamide: A Case Report and Literature Review.Frontiers in oncology · 2021Article
- Pegloticase hypersensitivity desensitisation: an outpatient, 3-bag, 12-step protocol.BMJ case reports · 2020Article
- Patients with high-grade alectinib-induced skin rash: How do we desensitize these patients? A case report and review of literature.SAGE open medical case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug desensitization is procedure by which patients can be tolerized to medications that have previously induced hypersensitivity reactions. Initially used in treating hypersensitivity reactions to antibiotics, desensitization is now frequently used in the setting of allergy to chemotherapy drugs and biologics, thus widening the clinical applicability of this procedure which has been proven to be quite safe and effective in improving clinical outcomes, mainly by allowing patients to remain on preferred first-line therapy. This paper reviews the history, application, and safety studies of drug desensitization for chemotherapy and biologics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.